P4

Progesterone

Hormones

What is Progesterone?

Progesterone is a steroid hormone primarily produced by the corpus luteum in the ovary following ovulation, and by the placenta during pregnancy. The adrenal glands also produce small amounts in both men and women. Progesterone's name literally means "pro-gestation"—it is the hormone that prepares the uterine lining (endometrium) for implantation of a fertilized egg and maintains the early pregnancy until the placenta takes over hormone production around weeks 8–12. Beyond reproduction, progesterone has calming effects on the brain through its metabolite allopregnanolone, which acts on GABA receptors.

Progesterone levels are low during the follicular phase of the menstrual cycle (before ovulation). After ovulation, the corpus luteum produces progesterone, causing levels to rise significantly during the luteal phase. This rise in progesterone transforms the endometrium from a proliferative state to a secretory state capable of supporting embryo implantation. If pregnancy does not occur, the corpus luteum degenerates, progesterone drops, and menstruation begins. During pregnancy, progesterone levels rise dramatically, reaching 10–20 times the luteal phase peak by the third trimester. Progesterone testing is most commonly used to confirm ovulation and evaluate luteal phase function.

Why It Matters

Progesterone is essential for establishing and maintaining pregnancy. Inadequate progesterone during the luteal phase (luteal phase defect) can prevent implantation or lead to early miscarriage. Progesterone also plays a role in regulating the menstrual cycle—without adequate progesterone, unopposed estrogen can lead to endometrial hyperplasia and increased risk of endometrial cancer. In fertility medicine, progesterone monitoring and supplementation are standard components of treatment. Additionally, progesterone has effects on mood, sleep, body temperature, and breast tissue development.

Normal Reference Ranges

GroupRangeUnit
Women (follicular phase)0.1–0.9ng/mL
Women (mid-luteal phase)5–20ng/mL
First Trimester Pregnancy11–44ng/mL
Adult Men0.1–0.5ng/mL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High P4 Levels Mean

Common Causes

  • Pregnancy (physiologically elevated)
  • Ovulation (normal luteal phase rise)
  • Congenital adrenal hyperplasia (21-hydroxylase deficiency)
  • Ovarian cysts (corpus luteum cysts)
  • Adrenal tumors or ovarian tumors
  • Molar pregnancy
  • Exogenous progesterone supplementation

Possible Symptoms

  • Drowsiness and fatigue
  • Bloating and breast tenderness
  • Mood changes and irritability
  • Constipation
  • Dizziness
  • Headaches
  • Acne

What to do: High progesterone in a non-pregnant woman should first prompt exclusion of pregnancy. If not pregnant, elevated progesterone in the luteal phase is normal and confirms ovulation. Persistently elevated progesterone outside the expected cycle timing may indicate congenital adrenal hyperplasia (check 17-hydroxyprogesterone), corpus luteum cysts, or rarely ovarian/adrenal tumors. In the context of exogenous progesterone supplementation (IVF, hormone therapy), elevated levels are expected and dose adjustments are guided by clinical response.

What Low P4 Levels Mean

Common Causes

  • Anovulation (no ovulation occurred)
  • Luteal phase defect (inadequate corpus luteum function)
  • Threatened miscarriage or ectopic pregnancy
  • Polycystic ovary syndrome (PCOS)
  • Hypothalamic amenorrhea
  • Hyperprolactinemia
  • Menopause

Possible Symptoms

  • Irregular or absent menstrual periods
  • Difficulty getting pregnant or recurrent miscarriage
  • Premenstrual spotting
  • Short menstrual cycles (short luteal phase)
  • Anxiety and mood changes
  • Insomnia or disrupted sleep
  • Hot flashes (in menopause)

What to do: Low mid-luteal progesterone (below 3 ng/mL measured 7 days after expected ovulation) strongly suggests anovulation. Causes of anovulation should be investigated with FSH, LH, estradiol, thyroid function, and prolactin. In women with confirmed ovulation but low luteal progesterone and infertility, progesterone supplementation (vaginal or intramuscular) during the luteal phase may be prescribed. Women with PCOS may benefit from ovulation induction with letrozole or clomiphene. In early pregnancy, low progesterone may indicate an at-risk pregnancy, and supplementation is sometimes used, though evidence for its benefit in preventing miscarriage is mixed outside of IVF.

When Is P4 Testing Recommended?

  • On day 21 of the menstrual cycle (or 7 days after suspected ovulation) to confirm ovulation
  • When evaluating infertility or recurrent pregnancy loss
  • During early pregnancy when miscarriage or ectopic pregnancy is suspected
  • When monitoring progesterone supplementation during fertility treatments

Frequently Asked Questions

Day 21 testing is based on a typical 28-day cycle where ovulation occurs on day 14, making day 21 approximately 7 days post-ovulation—when progesterone from the corpus luteum should be at its peak (the mid-luteal phase). A level above 3 ng/mL confirms that ovulation occurred, while levels above 10 ng/mL suggest a robust luteal phase. However, if your cycle is longer or shorter than 28 days, the timing should be adjusted. The key is testing 7 days after ovulation, not necessarily day 21. For example, if you ovulate on day 18, testing should be on day 25. Ovulation predictor kits or basal body temperature tracking can help identify the correct timing.
This is an area of active research with nuanced evidence. In women undergoing IVF, luteal phase progesterone supplementation is standard of care and clearly improves pregnancy rates, because the egg retrieval process removes the corpus luteum. In natural conception, the evidence is less clear. The large PRISM trial showed that vaginal progesterone did not significantly improve live birth rates in women with early pregnancy bleeding overall, but subgroup analysis suggested a benefit in women with a history of recurrent miscarriage. Current guidelines recommend progesterone supplementation for women with three or more prior miscarriages. Discuss with your fertility specialist or OB-GYN whether supplementation is appropriate for your situation.
Premenstrual syndrome (PMS) and its severe form, premenstrual dysphoric disorder (PMDD), occur during the luteal phase when progesterone levels are elevated. Interestingly, PMDD is not caused by abnormal progesterone levels, but rather by an abnormal sensitivity of the brain to normal progesterone fluctuations—specifically to its metabolite allopregnanolone, which affects the GABA neurotransmitter system. This is why women with PMDD have normal hormone levels but abnormal mood responses. Treatment for PMDD includes SSRIs (which can be taken just during the luteal phase), hormonal contraceptives that suppress ovulation, and in severe cases, GnRH agonists. Progesterone supplementation is generally not effective for PMDD and may worsen symptoms in sensitive individuals.

Related Biomarkers

E2EstradiolLHLuteinizing HormoneFSHFollicle-Stimulating Hormone

Want your P4 levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.